Please provide your email address to receive an email when new articles are posted on . Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Erin Phillips, MPH, RD, CDCES, about how diabetes care and ...
1don MSN
The rise of 'agonorexia': People are developing brand new eating disorders on GLP-1 agonist drugs
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under ...
Hosted on MSN
Weight loss program shown to improve eating disorder symptoms in at-risk people with type 2 diabetes
An intensive low-energy diet program, similar to the "NHS Type 2 Diabetes Path to Remission", significantly improved eating disorder symptoms in people with type 2 diabetes and excess weight who were ...
One in four patients with insulin-dependent diabetes aged 16 years and older also exhibit some kind of eating disorder symptoms, according to a recent meta-analysis conducted at the University of ...
An intensive low-energy diet programme, similar to the NHS Type 2 Diabetes Path to Remission, significantly improved eating disorder symptoms in people with type 2 diabetes and excess weight who were ...
Welcome to The Thin Line, The New York Post’s new series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold ...
Dry fasting, the practice of going without food and water, has enthusiastic advocates on TikTok, X, YouTube, and other social media platforms. Devotees claim a wide range of health effects, but ...
A recent study highlights a surprising potential benefit of diabetes and obesity drugs, GLP-1 receptor agonists, in improving ...
ScienceAlert on MSN
A 'Hidden' Metabolic Disorder May Not Show Up on Your Scale, Researchers Say
A metric that looks beyond height and weight to underlying biological markers of metabolic health is providing revised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results